Compared with normal controls, ATG16L2, BAK1, RAB24, RGS19, ULK2, and WDFY3 were upregulated, whereas CAPN10, RPS6KB1, and CASP1 were downregulated in AD patients. This evidence concerns the gene ATG16L2 and Alzheimer disease.